|Day Low/High||33.47 / 33.73|
|52 Wk Low/High||29.83 / 37.39|
The Trump administration's executive order on tax regulations could revive the defunct Allergan-Pfizer merger.
Pfizer Inc. (NYSE:PFE) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of BESPONSA ® ...
Pfizer Inc. today announced the launch of the company's Antimicrobial Testing Leadership and Surveillance (ATLAS) website, which is designed to provide physicians and the global health community with easy access to critical...
Postmenopausal women already have a broad menu of locally administered estrogen therapy products to treat vulvar and vaginal atrophy.
Pfizer Inc. invites investors and the general public to listen to a webcast of the Annual Meeting of Shareholders at 9:00 a.
Pfizer launched a Remicade biosimilar in November.
A study of analyst recommendations at the major brokerages shows that Pfizer Inc is the #15 broker pick, on average, out of the 30 stocks making up the Dow Jones Industrial Average, according to ETF Channel. Within the broader S&P 500, when components were ranked in terms of analyst favorites, PFE claims the #253 spot.
JNJ's diabetes and oncology franchises will also be key when the New Brunswick, N.J.-based healthcare giant reports first-quarter numbers Tuesday morning.
The FDA action was a win for Pfizer because Xeljanz escapes competition for one year or more.
Gilead, Pfizer, Abbvie stand to gain from Lilly and Incyte Rheumatoid Arthritis Setback.
The EpiPen-maker has received a letter from the FDA about its manufacturing facility in Nashik, India.
Eli Lilly has become the new go-to name in the pharmaceutical space, even over Johnson & Johnson, Cramer said.
OncoMed Pharmaceuticals, Geron and Akorn were among the biotech stock movers in premarket trading on Monday.
The media giant has asked the same law firm that conducted an investigation into former Fox News CEO Roger Ailes, who was ousted in July.
These stocks should be part of a strong first-quarter earnings season.
David Hung will become Axovant's CEO after completing the $14 billion sale of Medivation to Pfizer.
Not only are many members of the Trump administration incredibly rich, but they are active investors as well.
Washington needs to do more, Gottlieb says at his confirmation hearing.
The pharmaceutical giant has an attractive yield supported by double-digit earnings growth.
The maker of the EpiPen seems incapable of overcoming its troubles.
The biotechnology sector is enjoying robust recovery, driving Big Pharma shares to lofty levels. But this biotech stalwart is a great value play now.
We know that we are in the era when index managers are ascendant.
Pfizer Inc. (NYSE:PFE) today announced that the U.
Subscribers to Dividend Stock Advisor will now receive Income Seeker, our newest premium product.
This month's resilience in the market has a lot to do with short squeezes in big tech names.
Armed with an arsenal of vaccines in its product pipeline, this small biotech company is ready to rocket.
Jim Cramer says Pfizer needs to do a deal and buy someone; and he thinks Raytheon is a terrific stock.